Skip to content
C 42C 42C 42

Drawing based on the label description. No photo yet.

“Torsemide Tablets, USP 20 mg are available as white to off-white, capsule shaped, uncoated tablets, debossed with bisect between "C" and "42" on one side and plain on other side”

C 42 pill

Pill with imprint C 42 is white, capsule, 11 mm and has been identified as Torsemide 20 mg. It is used for high blood pressure, heart failure and swelling from fluid buildup. It is supplied by Chartwell Rx, LLC.

Torsemide 20 mg

Imprint
C 42
Strength
20 mg
Used for
High blood pressure, heart failure and swelling from fluid buildup
Color
White
Shape
Capsule / oblong
Size
11 mm
Score
Breaks into 2 pieces
Form
Tablet
Manufacturer
Chartwell Rx, LLC
Drug class
Loop diuretic (water pill)
NDC
62135-820, 62135-820-90

Source: the official drug label on DailyMed (US National Library of Medicine). Last checked .

Report a mistake

Please do not include personal health information. For questions about your medicine, ask a pharmacist.

All Torsemide pills and guides

What is Torsemide used for?

Torsemide is used for high blood pressure, heart failure and swelling from fluid buildup.

Medicine type
Loop diuretic (water pill)
Official uses from the US prescribing label

Edema

Torsemide tablets are indicated for the treatment of edema associated with heart failure, renal disease or hepatic disease.

Hypertension

Torsemide tablets are indicated for the treatment of hypertension, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. These benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes including the class to which this drug principally belongs. There are no controlled trials demonstrating risk reduction with torsemide.

Control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise, and limited sodium intake. Many patients will require more than one drug to achieve blood pressure goals. For specific advice on goals and management, see published guidelines, such as those of the National High Blood Pressure Education Program’s Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC).

Numerous antihypertensive drugs, from a variety of pharmacologic classes and with different mechanisms of action, have been shown in randomized controlled trials to reduce cardiovascular morbidity and mortality, and it can be concluded that it is blood pressure reduction, and not some other pharmacologic property of the drugs, that is largely responsible for those benefits. The largest and most consistent cardiovascular outcome benefit has been a reduction in the risk of stroke, but reductions in myocardial infarction and cardiovascular mortality also have been seen regularly.

Elevated systolic or diastolic pressure causes increased cardiovascular risk, and the absolute risk increase per mmHg is greater at higher blood pressures, so that even modest reductions of severe hypertension can provide substantial benefit. Relative risk reduction from blood pressure reduction is similar across populations with varying absolute risk, so the absolute benefit is greater in patients who are at higher risk independent of their hypertension (for example, patients with diabetes or hyperlipidemia), and such patients would be expected to benefit from more aggressive treatment to a lower blood pressure goal.

The antihypertensive effects of torsemide are on the average greater in black patients than in nonblack patients. Some antihypertensive drugs have smaller blood pressure effects (as monotherapy) in black patients, and many antihypertensive drugs have additional approved indications and effects (e.g., on angina, heart failure, or diabetic kidney disease). These considerations may guide selection of therapy.

Torsemide can be used alone or in combination with other antihypertensive agents.

From the FDA-approved label on DailyMed (published Aug 31, 2026).

Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.

Is this your pill? Check every detail

  • One side shows C 42 and the other side is plain.
  • It is white, capsule, 11 mm.
  • Its score line and coating match the details on this page.
  • It came from a pharmacy package that names the same drug.

Ingredients

Active: Torsemide

Inactive: Silicon Dioxide, Lactose Monohydrate, Magnesium Stearate, Microcrystalline Cellulose, Crospovidone, Unspecified

Other pills with imprint C 4 2

Same imprint, different listing. Check the color, size and maker against your pill.

Pills that look similar but are different drugs

Same color and shape, different medicine. This is why the imprint matters.

Other Torsemide pills